Canabo Medical (CMM.V) is poised to capitalize on the newest growth segment in the medical marijuana sector – big data. Chris Parry speaks with Advisory Board member, James Megann, and Executive Chairman, Dr. Neil Smith, about the company, it’s direction and how it will impact shareholder value. Have a look!

Watch live video from EquityDotGuru on www.twitch.tv
FULL DISCLOSURE: Canabo Medical is an EQUITY.GURU client.

Written By:

Gaalen Engen

More By This Author
Tags:
Cannabis
Livestreams
Parry
Research
Series
big data
Canabo Medical
CMM.V
Dr. Neil Smith
James Megann
Medical marijuana
0 0 votes
Article Rating
Subscribe
Notify of
guest
1 Comment
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Jack

These guys need to work on making their current shops profitable, all of their expansion is meaningless if they can’t figure out how to monetize their core business model. Next few quarters need to bring good news or this stock will drop even faster than it has the past month. The fact that Aphria sold off 2.5m shares of this company certainly does not inspire confidence.